Trending...
- Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
CLEVELAND, July 8, 2021 /PRNewswire/ -- The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2021 class of Harrington Scholar-Innovators. The scholar awards will support a diverse set of drug discovery projects including new treatments for multiple cancers, cardiovascular disease, Graft vs. Host disease, liver injury/fibrosis (NASH), Parkinson's disease, and the emerging field of longevity and aging.
The Harrington Discovery Institute—part of The Harrington Project for Discovery & Development—was established in 2012 to accelerate the development of new treatments to address major unmet needs in medicine and society. Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and potential for clinical impact. In addition to grant funding, Harrington provides guidance and oversight in all aspects of drug development through its Therapeutics Development Center, while taking no rights to intellectual property.
More on Ohio Pen
"We are incredibly inspired by the brilliant science demonstrated by these eight physician-scientists," said Jonathan S. Stamler, MD, President of the Harrington Discovery Institute at University Hospitals and Robert S. and Sylvia K. Reitman Family Foundation Distinguished Professor of Cardiovascular Innovation and Professor of Medicine and of Biochemistry at Case Western Reserve University. "In surrounding each Scholar with an experienced pharma and business development team with a track record of bringing new drugs to market, we are maximizing the therapeutic potential of great science."
The selected Scholars have access to several rounds of capital (up to a total of $700,000) through their affiliation with the Harrington Discovery Institute, as well as facilitated access to our mission-aligned commercial partners Advent-Harrington Impact Fund and BioMotiv, and to our charitable partner Morgan Stanley GIFT Cures.
More on Ohio Pen
The 2021 Harrington Scholar-Innovator Award recipients, their organizations and fields of research are:
Jennifer Chen, MD – University of California, San Francisco
Reversing Liver Fibrosis
John Chorba, MD – University of California, San Francisco
A Novel Treatment for Atherosclerosis
Joseph Contessa, MD, PhD – Yale University
A New Target and Drug for Lung Cancer
Toren Finkel, MD, PhD – University of Pittsburgh
Anti-aging Agents
Maria Grazia Roncarolo, MD – Stanford University
New Cell Therapy for Transplantation
Aaron Schimmer, MD – University of Toronto
A Treatment for Multiple Cancers and Neurological Diseases
Jill Smith, MD – Georgetown University
A New Treatment for Pancreatic Cancer
Xinnan Wang, MD, PhD – Stanford University
Targeting and Treating Parkinson's Disease
SOURCE Harrington Discovery Institute
The Harrington Discovery Institute—part of The Harrington Project for Discovery & Development—was established in 2012 to accelerate the development of new treatments to address major unmet needs in medicine and society. Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and potential for clinical impact. In addition to grant funding, Harrington provides guidance and oversight in all aspects of drug development through its Therapeutics Development Center, while taking no rights to intellectual property.
More on Ohio Pen
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
"We are incredibly inspired by the brilliant science demonstrated by these eight physician-scientists," said Jonathan S. Stamler, MD, President of the Harrington Discovery Institute at University Hospitals and Robert S. and Sylvia K. Reitman Family Foundation Distinguished Professor of Cardiovascular Innovation and Professor of Medicine and of Biochemistry at Case Western Reserve University. "In surrounding each Scholar with an experienced pharma and business development team with a track record of bringing new drugs to market, we are maximizing the therapeutic potential of great science."
The selected Scholars have access to several rounds of capital (up to a total of $700,000) through their affiliation with the Harrington Discovery Institute, as well as facilitated access to our mission-aligned commercial partners Advent-Harrington Impact Fund and BioMotiv, and to our charitable partner Morgan Stanley GIFT Cures.
More on Ohio Pen
- Lake Norman Philharmonic - Free Community Concert
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- Kingship Hip Hop Sarah J Preston Announces A New Era of Creativity & Debuts T.I. on The front Cover
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
The 2021 Harrington Scholar-Innovator Award recipients, their organizations and fields of research are:
Jennifer Chen, MD – University of California, San Francisco
Reversing Liver Fibrosis
John Chorba, MD – University of California, San Francisco
A Novel Treatment for Atherosclerosis
Joseph Contessa, MD, PhD – Yale University
A New Target and Drug for Lung Cancer
Toren Finkel, MD, PhD – University of Pittsburgh
Anti-aging Agents
Maria Grazia Roncarolo, MD – Stanford University
New Cell Therapy for Transplantation
Aaron Schimmer, MD – University of Toronto
A Treatment for Multiple Cancers and Neurological Diseases
Jill Smith, MD – Georgetown University
A New Treatment for Pancreatic Cancer
Xinnan Wang, MD, PhD – Stanford University
Targeting and Treating Parkinson's Disease
SOURCE Harrington Discovery Institute
0 Comments
Latest on Ohio Pen
- 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
- MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
- RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
- Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
- Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
- Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor
- When Hope Feels Gone, Death2life Is Still Here!
- Viva Agave enters Connecticut via North American Beverage Selections
- Sebastian Stroeller Publishes "The MAP Language Canon" — The Complete Practitioner's Guide to Structural Conversation
- OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors
- GLADYS Magazine Celebrates their 18 Year Anniversary!
- New Townhome Building Released at Heritage at South Brunswick, Offering Private Perimeter Setting and Water Views
- Comics Veteran on Return of Teenage Mutant Ninja Turtles Characters, 3-D Projects, Collaboration with Original 'Star Wars' Toy Engineer
- Flexible Plan Investments Announces Retirement of Executive Vice President Renée Toth
- Sensory Education launches new neuro-affirming psychoeducation book, Sensory Diversity
- Break the Resume Mold: Career Valet Changes How Executives Hunt for Jobs
- James Dooley Named King of AEO at Ceremony in Leigh, England
- Calling all healthcare process experts: Share your ideas at #HSPI2027 in Orlando
- Joshua Terrell Studios Highlights How Industry Changes Are Shaping the Work of Photographers in Ohio